Concepedia

A.N. Chremos

AC

21

Publications

958

Citations

17

H-Index

1963

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Baylor College of Medicine

University of Alabama at Birmingham

Oklahoma Medical Research Foundation

A.N. Chremos is an author at United States Military Academy specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1963–1996

21

Publications

21

Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome

John M. Howard, A.N. Chremos, Martin J. Collen et al. · Gastroenterology · 1985 · 186 citations · Full text

, , +4

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin

Carlos A. Dujovne, A.N. Chremos, James L. Pool et al. · The American Journal of Medicine · 1991 · 110 citations

, , +8

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.

Charles L. Shear, Frank A. Franklin, Sandra S. Stinnett et al. · Circulation · 1992 · 82 citations · Full text

Effects of sulindac and indomethacin on renal prostaglandin synthesis

John R. Sedor, Susan L. Williams, A.N. Chremos et al. · Clinical Pharmacology & Therapeutics · 1984 · 71 citations

Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man

J H Lin, A.N. Chremos, K. C. Yeh et al. · European Journal of Clinical Pharmacology · 1988 · 51 citations

, , +9

Rows per page

1–5 of 21